vs
Five9, Inc.（FIVN）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
Five9, Inc.的季度营收约是REPLIGEN CORP的1.5倍（$300.3M vs $197.9M），REPLIGEN CORP同比增速更快（13.6% vs 7.8%），Five9, Inc.自由现金流更多（$77.3M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 10.3%）
Five9是全球领先的云原生联络中心软件及解决方案供应商，服务零售、医疗、金融服务、科技等行业的各规模企业，提供全渠道客户互动、AI驱动自动化、劳动力管理、数据分析等工具，助力企业提升客户体验与运营效率。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
FIVN vs RGEN — 直观对比
营收规模更大
FIVN
是对方的1.5倍
$197.9M
营收增速更快
RGEN
高出5.9%
7.8%
自由现金流更多
FIVN
多$59.8M
$17.6M
两年增速更快
RGEN
近两年复合增速
10.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $300.3M | $197.9M |
| 净利润 | — | $13.3M |
| 毛利率 | 55.4% | 52.5% |
| 营业利润率 | 6.6% | 9.0% |
| 净利率 | — | 6.7% |
| 营收同比 | 7.8% | 13.6% |
| 净利润同比 | — | 143.9% |
| 每股收益（稀释后） | $0.22 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FIVNRGEN
| Q4 25 | $300.3M | $197.9M | ||
| Q3 25 | $285.8M | $188.8M | ||
| Q2 25 | $283.3M | $182.4M | ||
| Q1 25 | $279.7M | $169.2M | ||
| Q4 24 | $278.7M | $174.1M | ||
| Q3 24 | $264.2M | $154.9M | ||
| Q2 24 | $252.1M | $154.1M | ||
| Q1 24 | $247.0M | $151.3M |
净利润FIVNRGEN
| Q4 25 | — | $13.3M | ||
| Q3 25 | $18.0M | $14.9M | ||
| Q2 25 | $1.2M | $14.9M | ||
| Q1 25 | $576.0K | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | $-4.5M | $-654.0K | ||
| Q2 24 | $-12.8M | $3.3M | ||
| Q1 24 | $-7.1M | $2.1M |
毛利率FIVNRGEN
| Q4 25 | 55.4% | 52.5% | ||
| Q3 25 | 55.0% | 53.2% | ||
| Q2 25 | 54.9% | 50.0% | ||
| Q1 25 | 55.0% | 53.6% | ||
| Q4 24 | 56.0% | 26.1% | ||
| Q3 24 | 53.8% | 50.0% | ||
| Q2 24 | 53.0% | 49.8% | ||
| Q1 24 | 53.6% | 49.5% |
营业利润率FIVNRGEN
| Q4 25 | 6.6% | 9.0% | ||
| Q3 25 | 5.6% | 8.9% | ||
| Q2 25 | -0.6% | 7.6% | ||
| Q1 25 | -1.9% | 3.9% | ||
| Q4 24 | 1.5% | -17.7% | ||
| Q3 24 | -5.8% | -5.1% | ||
| Q2 24 | -7.7% | 1.0% | ||
| Q1 24 | -8.4% | 1.3% |
净利率FIVNRGEN
| Q4 25 | — | 6.7% | ||
| Q3 25 | 6.3% | 7.9% | ||
| Q2 25 | 0.4% | 8.2% | ||
| Q1 25 | 0.2% | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | -1.7% | -0.4% | ||
| Q2 24 | -5.1% | 2.2% | ||
| Q1 24 | -2.9% | 1.4% |
每股收益（稀释后）FIVNRGEN
| Q4 25 | $0.22 | $0.24 | ||
| Q3 25 | $0.21 | $0.26 | ||
| Q2 25 | $0.01 | $0.26 | ||
| Q1 25 | $0.01 | $0.10 | ||
| Q4 24 | $0.16 | $-0.55 | ||
| Q3 24 | $-0.06 | $-0.01 | ||
| Q2 24 | $-0.17 | $0.06 | ||
| Q1 24 | $-0.10 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $232.1M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $785.8M | $2.1B |
| 总资产 | $1.8B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资FIVNRGEN
| Q4 25 | $232.1M | $767.6M | ||
| Q3 25 | $193.4M | $748.7M | ||
| Q2 25 | $205.5M | $708.9M | ||
| Q1 25 | $370.3M | $697.2M | ||
| Q4 24 | $362.5M | $757.4M | ||
| Q3 24 | $291.0M | $784.0M | ||
| Q2 24 | $175.7M | $809.1M | ||
| Q1 24 | $240.2M | $780.6M |
总债务FIVNRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益FIVNRGEN
| Q4 25 | $785.8M | $2.1B | ||
| Q3 25 | $775.3M | $2.1B | ||
| Q2 25 | $717.4M | $2.1B | ||
| Q1 25 | $664.3M | $2.0B | ||
| Q4 24 | $622.2M | $2.0B | ||
| Q3 24 | $565.6M | $2.0B | ||
| Q2 24 | $525.9M | $2.0B | ||
| Q1 24 | $483.6M | $2.0B |
总资产FIVNRGEN
| Q4 25 | $1.8B | $2.9B | ||
| Q3 25 | $1.8B | $2.9B | ||
| Q2 25 | $1.7B | $2.9B | ||
| Q1 25 | $2.1B | $2.9B | ||
| Q4 24 | $2.1B | $2.8B | ||
| Q3 24 | $2.0B | $2.8B | ||
| Q2 24 | $1.9B | $2.9B | ||
| Q1 24 | $1.9B | $2.8B |
负债/权益比FIVNRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $83.6M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $77.3M | $17.6M |
| 自由现金流率自由现金流/营收 | 25.8% | 8.9% |
| 资本支出强度资本支出/营收 | 2.1% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $201.2M | $93.9M |
8季度趋势，按日历期对齐
经营现金流FIVNRGEN
| Q4 25 | $83.6M | $25.7M | ||
| Q3 25 | $59.2M | $48.1M | ||
| Q2 25 | $35.1M | $28.6M | ||
| Q1 25 | $48.4M | $15.0M | ||
| Q4 24 | $49.8M | $39.2M | ||
| Q3 24 | $41.1M | $49.3M | ||
| Q2 24 | $19.9M | $42.2M | ||
| Q1 24 | $32.4M | $44.7M |
自由现金流FIVNRGEN
| Q4 25 | $77.3M | $17.6M | ||
| Q3 25 | $48.7M | $43.4M | ||
| Q2 25 | $31.6M | $21.5M | ||
| Q1 25 | $43.7M | $11.4M | ||
| Q4 24 | $40.5M | $33.6M | ||
| Q3 24 | $26.7M | $42.3M | ||
| Q2 24 | $13.1M | $37.4M | ||
| Q1 24 | $20.4M | $36.4M |
自由现金流率FIVNRGEN
| Q4 25 | 25.8% | 8.9% | ||
| Q3 25 | 17.0% | 23.0% | ||
| Q2 25 | 11.1% | 11.8% | ||
| Q1 25 | 15.6% | 6.8% | ||
| Q4 24 | 14.5% | 19.3% | ||
| Q3 24 | 10.1% | 27.3% | ||
| Q2 24 | 5.2% | 24.3% | ||
| Q1 24 | 8.3% | 24.0% |
资本支出强度FIVNRGEN
| Q4 25 | 2.1% | 4.1% | ||
| Q3 25 | 3.7% | 2.5% | ||
| Q2 25 | 1.2% | 3.9% | ||
| Q1 25 | 1.7% | 2.1% | ||
| Q4 24 | 3.3% | 3.2% | ||
| Q3 24 | 5.4% | 4.5% | ||
| Q2 24 | 2.7% | 3.1% | ||
| Q1 24 | 4.8% | 5.5% |
现金转化率FIVNRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | 3.29× | 3.23× | ||
| Q2 25 | 30.38× | 1.92× | ||
| Q1 25 | 84.00× | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
